A large gene panel analysis, including TP53, CTNNB1, and IDH2, revealed no additional oncogenic mutations, supporting SMARCB1 protein loss as the primary driver of this distinct carcinoma in the sinonasal tract [21, 27]. Here, SMARCB1 is linked to carcinoma.